To view this email as a web page, click here.
 
TOP DRUG NEWS
 
Drug distributor pays record fine
One of the largest distributors of pharmaceuticals agreed to pay a record $150 million civil penalty for alleged violations of the Controlled Substances Act (CSA).
Read more
 
HIV dual therapy shows promise
A dual-drug regimen to treat HIV could soon be a reality, according to results presented at the recent Conference on Retroviruses and Opportunistic Infections (CROI).
Read more
 
Muscular dystrophy drug launch halts after pricing concerns
Marathon Pharmaceuticals is temporarily pausing the launch of its drug to treat a rare form of muscular dystrophy (MD) after concerns over its $89,000 price tag.
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.